Key result
Breast cancer treatments, including anthracyclines, targeted therapies, and radiation, increase the risk of cardiovascular disease, highlighting the need for cardioprotective strategies.
Why the study?
Breast cancer therapies carry significant cardiotoxic effects and shared risk factors with cardiovascular disease, where early detection and treatment may reduce cardiac morbidity and mortality.
This review highlights the significant cardiotoxic risks of various breast cancer therapies and emphasizes the importance of early detection and cardioprotective strategies to reduce cardiovascular morbidity in cancer survivors.
Answers are grounded in this paper and cite their sources.
Raises awareness of cardiotoxicity in breast cancer survivors; leaves open integrated prevention strategies pending prospective trials.
Breast cancer is the most common malignancy affecting females worldwide and is also among the top causes of all cancer-related deaths. Cardiovascular disease (CVD) is known to have the highest rate of mortality in women. There are several risk factors for both CVD and breast cancer that overlap, such as diet, smoking, and obesity, and also the current breast cancer treatment has a significant detrimental effect on cardiovascular health in general. Patients with exposure to potentially cardiotoxic treatments, including anthracyclines, trastuzumab, and radiation therapy, are more likely to develop CVD than non-cancer controls. Early detection and treatment may reduce the risk of the development of cardiac morbidity and mortality and would increase the number of breast cancer survivors. This article provides a comprehensive overview of breast cancer, identifies shared risk factors among breast cancer and CVD, and the cardiotoxic effects of therapy. It also reviews possible prevention and treatment of CVD in breast cancer patients and reviews literature about chemoprevention of cardiac disease in the setting of breast cancer treatment.
No takes yet. Share an insight, caveat, or question.
Cherukuri et al. (2022) conducted a review in Breast cancer and cardiovascular disease. Breast cancer therapies was evaluated. Breast cancer treatments, including anthracyclines, targeted therapies, and radiation, increase the risk of cardiovascular disease, highlighting the need for cardioprotective strategies.
Synapse has enriched 10 related papers. Consider them for comparative context: